TherapeuticsMD, Inc. — Director's Dealing 2015

Dec 22, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2015-12-17

Reporting Person: Donegan Michael C (Vice President Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-17	Non-Qualified Stock Option (right to buy)	$8.92	A	100000	Acquired	2025-12-17	Common Stock (100000)	Direct

Footnotes

F1: The option vests in equal monthly installments over 12 months.